NephLong
Regonix Tablet
Details
40 mg
-
Product Name: Regonix
-
Generic Name: Regorafenib
Product Description:
Regonix is an oral multikinase inhibitor that targets various kinases involved in tumor angiogenesis, oncogenesis, and the tumor microenvironment. It is primarily used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma.
Dosage Form:
Film-coated tablet
Available Strengths (commonly available):
40 mg
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.